Cyclerion Therapeutics (CYCN) Total Current Liabilities (2019 - 2025)
Historic Total Current Liabilities for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $877000.0.
- Cyclerion Therapeutics' Total Current Liabilities rose 2528.57% to $877000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $877000.0, marking a year-over-year increase of 2528.57%. This contributed to the annual value of $725000.0 for FY2024, which is 6524.45% down from last year.
- Latest data reveals that Cyclerion Therapeutics reported Total Current Liabilities of $877000.0 as of Q3 2025, which was up 2528.57% from $800000.0 recorded in Q2 2025.
- In the past 5 years, Cyclerion Therapeutics' Total Current Liabilities registered a high of $13.5 million during Q1 2021, and its lowest value of $700000.0 during Q3 2024.
- Moreover, its 5-year median value for Total Current Liabilities was $4.9 million (2023), whereas its average is $5.6 million.
- Its Total Current Liabilities has fluctuated over the past 5 years, first crashed by 8086.58% in 2024, then skyrocketed by 2528.57% in 2025.
- Cyclerion Therapeutics' Total Current Liabilities (Quarter) stood at $11.1 million in 2021, then plummeted by 31.2% to $7.6 million in 2022, then crashed by 72.65% to $2.1 million in 2023, then crashed by 65.24% to $725000.0 in 2024, then rose by 20.97% to $877000.0 in 2025.
- Its last three reported values are $877000.0 in Q3 2025, $800000.0 for Q2 2025, and $1.1 million during Q1 2025.